This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Illingworth Research Group (Spain) Sociedad Limatada
Illingworth Research Group (Spain) Sociedad Limitada, commonly referred to as Illingworth Research, is a prominent clinical research organisation headquartered in Spain. Established in 2010, the company has rapidly expanded its operational footprint across Europe, providing comprehensive services in the pharmaceutical and biotechnology sectors. Specialising in clinical trial management, patient recruitment, and regulatory affairs, Illingworth Research distinguishes itself through its innovative approach and commitment to quality. The firm has achieved significant milestones, including successful collaborations with leading pharmaceutical companies, which have solidified its position in the competitive landscape of clinical research. With a focus on enhancing patient engagement and streamlining trial processes, Illingworth Research continues to be a trusted partner for organisations seeking to advance their clinical development programmes. Its dedication to excellence and strategic growth has earned it a notable reputation within the industry.
DitchCarbon Score
How does Illingworth Research Group (Spain) Sociedad Limatada's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Illingworth Research Group (Spain) Sociedad Limatada's score of 21 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Illingworth Research Group (Spain) Sociedad Limatada currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. The organisation is a current subsidiary of Syneos Health, Inc., and therefore, any climate commitments or emissions data may be inherited from this parent company. As a subsidiary, Illingworth Research Group aligns with the climate initiatives and targets set by Syneos Health, Inc. However, specific reduction targets or achievements for Illingworth Research Group are not detailed. The absence of documented reduction initiatives or climate pledges indicates that the company may still be in the process of establishing its own distinct climate strategy. Given the lack of direct emissions data and reduction commitments, it is essential for Illingworth Research Group to develop and communicate its climate action plans in line with industry standards to enhance transparency and accountability in its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 16,298,000 | 00,000,000 |
| Scope 2 | 9,704,000 | 0,000,000 |
| Scope 3 | 261,804,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Illingworth Research Group (Spain) Sociedad Limatada is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
